You are here: Industry Insights > acquisition

News List

AskBio Acquires BrainVectis contractpharma
April 23, 2020
Expands clinical pipeline for neurodegenerative diseases with Huntington’s disease gene therapy candidate.
Novartis expands ophthalmology pipeline with Amblyotech acquisition pharmaceutical-technology
April 21, 2020
Novartis has acquired US-based software startup Amblyotech, which is developing a digital treatment for amblyopia (lazy eye) that leads to vision loss in children and young adults.
Advarra Acquires IRB Company, Inc. contractpharma
April 21, 2020
Advarra, a provider of institutional review board (IRB), institutional biosafety committee (IBC), research technology solutions, and quality and compliance consulting services, has acquired IRB Company, Inc.
Seikagaku Acquires Dalton Pharma Services contractpharma
April 16, 2020
Earlier this year,?Global Healthcare Advisors (GHA)?announced the acquisition of Canada’s?Dalton Pharma Services?by Japan’s?Seikagaku Corporation (SKK).
Orgenesis to Acquire Tamir Bio Assets contractpharma
April 15, 2020
Aims to combine ranpirnase antiviral platform with Bioxome technology for enhanced payload delivery directly to cells.
Servier Acquires Cancer Biotech Symphogen contractpharma
April 08, 2020
Strengthens R&D pipeline by acquiring antibody pipeline and next-gen antibody technologies.
Servier agrees to acquire Symphogen pharmaceutical-technology
April 07, 2020
French pharmaceutical company Servier has signed a definitive agreement to acquire 100% shares in Danish therapeutic antibody discovery firm Symphogen.
Frontage Laboratories Acquires Biotranix contractpharma
April 06, 2020
Frontage Holdings Corporation, a contract research organization (CRO) providing integrated, science-driven research, analytical and development services with presence in both North America and China.
DSM completes acquisition of Human Milk Oligosaccharides supplier, Glycom expresspharma
April 06, 2020
There is significant interest in HMO use as a dietary supplement and potentially in food and beverage and pet food applications, and in fulfilling unmet medical nutrition needs, such as irritable bowel syndrome.
Aurobindo, Sandoz call off $900 million deal expresspharma
April 03, 2020
In September 2018, Aurobindo Pharma had said its US subsidiary has entered into a pact to acquire commercial operations and three manufacturing facilities in America from Sandoz Inc.